Sequence information
Variant position: 64 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1114 The length of the canonical sequence.
Location on the sequence:
QAAGTPLLYVHALRDAPEEV
P SFRLGQHLYGTYRTRLHENN
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QAAGTPLLYVHALRDAPEEVP SFRLGQHLYGTYRTRLHENN
Mouse QPAGTPLLYVHALRDAPGEVP SFRLGQHLYGVYRTRLHEND
Rat QPAGTPLLYVHALRDAPGEVP SFRLGQYLYGVYRTRLHEND
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
29 – 1114
Proto-oncogene tyrosine-protein kinase receptor Ret
Chain
29 – 707
Extracellular cell-membrane anchored RET cadherin 120 kDa fragment
Topological domain
29 – 635
Extracellular
Literature citations
Mutations of the RET proto-oncogene in Hirschsprung's disease.
Edery P.; Lyonnet S.; Mulligan L.M.; Pelet A.; Dow E.; Abel L.; Holder S.; Nihoul-Fkete C.; Ponder B.A.J.; Munnich A.;
Nature 367:378-380(1994)
Cited for: VARIANTS HSCR1 LEU-32; LEU-64; GLN-330 AND LEU-393;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.